M.D.C. Holdings, Inc. (NYSE:MDC) – Equities researchers at KeyCorp lifted their FY2018 EPS estimates for M.D.C. in a research report issued to clients and investors on Wednesday. KeyCorp analyst K. Zener now expects that the construction company will earn $2.89 per share for the year, up from their previous estimate of $2.40. KeyCorp also issued estimates for M.D.C.’s FY2019 earnings at $3.27 EPS.
M.D.C. (NYSE:MDC) last issued its quarterly earnings results on Thursday, February 1st. The construction company reported $0.43 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.68 by ($0.25). The company had revenue of $704.26 million during the quarter, compared to analysts’ expectations of $722.48 million. M.D.C. had a return on equity of 11.00% and a net margin of 5.50%. M.D.C.’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same period last year, the firm posted $0.78 earnings per share.
M.D.C. (NYSE MDC) opened at $29.48 on Monday. The company has a quick ratio of 3.34, a current ratio of 10.01 and a debt-to-equity ratio of 0.78. The firm has a market cap of $1,654.51, a PE ratio of 11.10, a P/E/G ratio of 0.64 and a beta of 1.34. M.D.C. has a fifty-two week low of $24.99 and a fifty-two week high of $35.18.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 21st. Shareholders of record on Wednesday, February 7th will be issued a dividend of $0.30 per share. The ex-dividend date is Tuesday, February 6th. This is an increase from M.D.C.’s previous quarterly dividend of $0.25. This represents a $1.20 annualized dividend and a yield of 4.07%. M.D.C.’s dividend payout ratio is 48.10%.
In other M.D.C. news, Director Herbert T. Buchwald sold 28,350 shares of the company’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $31.52, for a total transaction of $893,592.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director David Siegel sold 2,500 shares of the company’s stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $31.83, for a total value of $79,575.00. The disclosure for this sale can be found here. 25.30% of the stock is owned by corporate insiders.
Institutional investors and hedge funds have recently made changes to their positions in the company. Amalgamated Bank bought a new stake in shares of M.D.C. during the second quarter valued at about $202,000. Parsec Financial Management Inc. bought a new stake in shares of M.D.C. during the fourth quarter valued at about $203,000. Quantitative Systematic Strategies LLC bought a new stake in shares of M.D.C. during the fourth quarter valued at about $260,000. Sawgrass Asset Management LLC bought a new stake in shares of M.D.C. during the third quarter valued at about $262,000. Finally, Parametrica Management Ltd bought a new stake in shares of M.D.C. during the third quarter valued at about $285,000. Hedge funds and other institutional investors own 73.84% of the company’s stock.
M.DC Holdings, Inc is engaged in two primary operations, including homebuilding and financial services. The Company’s segments include West, including segments located in Arizona, California, Nevada and Washington; Mountain, including segments located in Colorado and Utah; East, including segments located in Virginia, Florida and Maryland, which includes Pennsylvania and New Jersey; mortgage operations, including HomeAmerican Mortgage Corporation, and Other, which includes Allegiant Insurance Company, Inc, StarAmerican Insurance Ltd., American Home Insurance Agency, Inc and American Home Title and Escrow Company.
Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.